Mr. Martin joined Pacific Biosciences in 2004 as a seasoned executive with a 25-year track record managing leading edge technologies, new ventures, and high growth businesses. Previously, Mr. Martin was Chairman, President and CEO of ONI Systems?a high-speed optical telecommunications company he founded in 1998 and took public in 2000. Named the Fastest Growing Company in Silicon Valley in 2001, ONI was sold to Ciena in 2002. After its sale, Mr. Martin served as a consultant to Ciena, a CEO in residence at the venture capital firm of Kleiner Perkins Caufield and Byers, and was a Director at Cloudshield Technologies.
Prior to ONI, Mr. Martin was President and Director of 3DO?an interactive gaming company. His earlier experience includes running desktop engineering for Apple Computer and founding Ridge Computers?designer of the world's first commercial reduced instruction set computing (RISC) minicomputer.
Mr. Martin received a BS in Electrical Engineering at Rutgers University, New Brunswick, New Jersey. Mr. Martin currently serves on the Board of Directors of Pacific Biosciences and Infinera.
Related Links: http://www.pacificbiosciences.com
Last Updated: Wed, Jan 14, 2009
|Video||Don't Prolong Your Exit||Hugh Martin||Pacific Biosciences||01:06||01/2009|
|Video||Believe in the Value of Investors||Hugh Martin||Pacific Biosciences||01:07||01/2009|
|Video||Bravely Take On the Big Players||Hugh Martin||Pacific Biosciences||01:07||01/2009|
|Video||People are Everything in the Start-Up||Hugh Martin||Pacific Biosciences||01:12||01/2009|
|Video||The Impact of a CEO||Hugh Martin||Pacific Biosciences||01:18||01/2009|
|Video||Overcommunicate Frequently||Hugh Martin||Pacific Biosciences||01:21||01/2009|
|Video||The Benefits of Stockpiling Cash||Hugh Martin||Pacific Biosciences||02:29||01/2009|
|Video||Hiring the Best in Human Resources||Hugh Martin||Pacific Biosciences||02:42||01/2009|
|Video||Building Resistance to Acquisition||Hugh Martin||Pacific Biosciences||06:03||01/2009|
|Podcast||13 Mistakes and 13 Brilliant Strokes||Hugh Martin||Pacific Biosciences||54:30||01/2009|